Craig T. Wallington‐Beddoe

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Sebastian Grosicki, Maryana Simonova, Ivan Špıčka et al. · The Lancet · 2020 · 310 citations · Full text

Hematological Malignancy, Once-per-week Selinexor, Medicine +7

Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia

Jason A. Powell, Alexander C. Lewis, Wenying Zhu et al. · Blood · 2016 · 85 citations · Full text

FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells

Craig T. Wallington‐Beddoe, John Hewson, Kenneth F. Bradstock et al. · Autophagy · 2011 · 76 citations · Full text

Chemoprevention Strategy, Apoptosis, Immunology +20

Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies

Alexander C. Lewis, Craig T. Wallington‐Beddoe, Jason A. Powell et al. · Cell Death Discovery · 2018 · 74 citations · Full text

Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing <i>MYC</i> Expression

Craig T. Wallington‐Beddoe, Jason A. Powell, Daochen Tong et al. · Cancer Research · 2014 · 73 citations

Mixed-phenotype Acute Leukemia, Immunology, Myc Protein +16